Clinical Trial: Prospective Study on the Clinical Prognosis of Bilateral Central Lymph Node Dissection in the Patients With Unilateral Thyroid Papillary Carcinoma
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title:
Brief Summary: This study recruit the patients with unilateral papillary thyroid cancer before operation,the patients agree to enter the test,and divided into experimental and control group.experimental group patients receive the surgery including unilateral thyroid lobectomy and bilateral central lymph node dissection.and control group receive the surgery including unilateral thyroid lobectomy and unilateral central lymph node dissection.last the investigators compare numbers of patient with tumor recurrence and metastasis rate of 5 years,numbers of metastatic lymph node,and numbers of participants with adverse events related to treatment between two groups in order to evaluate the significance of bilateral lymph node dissection.
Detailed Summary:
Sponsor: Fujian Medical University
Current Primary Outcome:
- tumor recurrence [ Time Frame: 5 years ]numbers of patients with tumor recurrence
- numbers of metastatic lymph node [ Time Frame: 1 years ]numbers of metastatic lymph node
- adverse events related to treatment [ Time Frame: 1 years ]numbers of participants with adverse events including recurrent nerve injury，parathyroid injury，hemorrhage
Original Primary Outcome: Same as current
Current Secondary Outcome:
- relations between the lymph metastasis and TNM staging [ Time Frame: 1 years ]Coefficient R (SPSS software for correlation analysis)
- relations between the lymph metastasis and tumor location [ Time Frame: 1 years ]Coefficient R (SPSS software for correlation analysis)
Original Secondary Outcome: Same as current
Information By: Fujian Medical University
Dates:
Date Received: December 13, 2015
Date Started: December 2015
Date Completion: December 2016
Last Updated: January 6, 2016
Last Verified: January 2016
